End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.019 AUD | +5.56% | +11.76% | -5.00% |
04-30 | Transcript : Syntara Limited, Q3 2024 Earnings Call, Apr 30, 2024 | |
04-10 | Syntara Reaches 50% Recruitment in Phase 2 Trial for Bone Marrow Cancer Treatment | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SYNTARA LIMITED | Other Pharmaceuticals | +5.56% | +11.76% | -5.00% | -65.45% | -92.83% | 15.03M |
Technical Rankings Surperformance
- Stock Market
- Equities
- SNT Stock
- Charts Syntara Limited
- Comparison Chart